BNET Industries
Market Cap:$12.3B
Last Fiscal Year Sales:$3.7B
- Public
- US
Dow Jones Description
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn., St. Jude Medical employs approximately 14,000 people worldwide and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, electrophysiology catheters, mapping and visualization systems, vascular closure devices, heart valve replacement and repair products, and neurostimulation devices.
Number of Employees 14,000
Peer Companies
NAICS Code Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
Recent Events
-
SJM Releases New Neurostimulator Programming Software
-
Morgan Joseph Initiates Coverage on St. Jude Medical STJ with a Buy; High-Quality Name in...
-
UPDATE: St. Jude Leaves Trade Group AdvaMed In Tax Dispute
-
Zacks Analyst Blog Highlights: Morgan Stanley, Goldman Sachs, St.
-
Was the St. Jude sell-off overdone?
-
Canaccord Adams Downgrades St. Jude Medical Inc. STJ to Hold
-
David Moenning's Daily State of the Markets: Voting With Their Feet
-
Edwards Lifesciences Q3 Profit More Than Doubles; Updates FY09 Outlook
-
Uncertainty in face of reform
-
St. Jude Medical Announces Australian Launch of Devices that Diagnose and Treat Abnormal Heart Rhythms
-
Zacks Analyst Blog Highlights: Fannie Mae, Freddie Mac, St. Jude Medical, Medtronic and Boston...
-
Micell gets investment from St. Jude Medical
-
$15 million infusion for Micell
-
St. Jude Medical to Showcase Complete Cardiovascular Access, Intervention and Hemostasis...
-
FDA clears St. Jude cardiac mapping system
-
St. Jude Medical Announces European Launch of New Version of
-
St. Jude Medical Announces European Launch of New Version of Remote Patient Care Network
-
Notable Analyst Rating Changes 8/26: STJ, GMR, KMT, CP Upgraded; BKC, AMED, MDAS Downgraded
-
UPDATE: St. Jude 2Q Net Up 14%, But ICDs Raise Questions
News & Analysis
Filter by
fda and st. jude medical inc. - All News and Analysis
First Wi-Fi pacemaker in U.S. gives patient freedom
BNET
- 2009-08-11
By Ben Gruber NEW YORK (Reuters) - After relying on a pacemaker for 20 years, Carol Kasyjanski has become the first American recipient of a wireless pacemaker that allows her doctor to monitor her health from afar -- over the Internet. When Kasyjanski heads to St. Francis Hospital in Roslyn,...
New York Woman Receives Wireless Pacemaker
BNET
- 2009-08-10
NEW YORK (Reuters) - After relying on a pacemaker for 20 years, Carol Kasyjanski has become the first American recipient of a wireless pacemaker that allows her doctor to monitor her health from afar?over the Internet. When Kasyjanski heads to St. Francis Hospital in Roslyn, New York, for a routine...
St. Jude Medical Announces FDA Clearance and CE Mark Approval of Strada Carotid Guiding Sheath
- 2008-05-07
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration FDA clearance and European CE Mark approval of the Strada[TM] Carotid Guiding Sheath, a flexible tube through which physicians can deliver balloon catheters, stents and other tools to open blockages in the carotid arteries....
St. Jude Medical Receives FDA and CE Mark Approvals for the World's Smallest, Longest-Lasting Rechargeable Neurostimulator to Treat Chronic Pain
- 2008-04-14
Eon Mini Combines Greater Patient Comfort With 10-Year Battery Longevity
St. Jude Medical Receives FDA and CE Mark Approvals of Extended 10-Year Battery Life Claim for Rechargeable Neurostimulator
- 2008-02-14
Eon Neurostimulation System provides chronic pain patients with longest-lasting battery available
St. Jude Medical Announces FDA and European CE Mark Approval of the QuickFlex Family of Leads
- 2008-01-22
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration FDA and European CE Mark approval of the QuickFlex[TM] family of left-heart leads to treat heart failure patients.
St. Jude Medical Announces FDA and European CE Mark Approvals of Durata Defibrillation Lead
- 2008-01-17
Next Generation Lead Focuses on Ease of Implantation
St. Jude Medical Receives FDA Clearance for ACross Transseptal Access System
- 2007-07-26
New device increases control and reduces complexity of critical step in accessing the left atrium
St. Jude Medical Announces FDA Clearance of the Proxis Embolic Protection System
- 2007-07-25
Proxis is Industry's First "Upstream" Embolic Protection System
St. Jude Medical Announces FDA and CE Mark Approvals Of QuickOpt Timing Cycle Optimization For Additional Heart Failure Devices
- 2007-06-28
Approval provides timing-cycle optimization to more patients worldwide
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
Glass Door
St. Jude Medical
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- More Insurance Competition Will Not Reduce Costs 2 votes
